Health Care Equipment & Services

Veeva’s insider buying by President Eleni Nitsa signals strong confidence in its cloud‑based life‑science platform’s near‑term growth, offering investors a bullish outlook.

Teladoc insider sales show portfolio rebalancing, not panic—investors see modest price impact amid steady growth and strong fundamentals.

Alpha Tau Medical CFO’s bold insider buy at $2.98 signals confidence amid a 23% weekly jump, hinting at upside for oncology device investors.

Labcorp insider Kyle Kathryn W buys 256 RSUs amid strong earnings, partnership news & rising stock—showing management’s confidence in long‑term diagnostics growth.

Insightful analysis of Kurt Hilzinger’s RSU buys shows Humana’s Medicare growth and insider confidence—why investors are watching the stock closely.

Insight: Gracey Craig’s 10(b)(5) buy at OMADA Health signals confidence amid a rally—watch insider trades for clues on future upside.

Agilon Health CFO’s July 1 sale of 2,311 shares: a routine liquidity move amid strategic growth, not a signal of trouble, says analysts.

Guardant Health insider buys signal confidence—executives buying shares as the company’s liquid‑biopsy growth gains momentum and valuation may rise.

Zimmer Biomet insider Hilado Maria Teresa’s phantom‑stock purchase signals confidence in the company’s AI‑driven R&D expansion, hinting at a future upside for long‑term investors.

SeaStar insiders, including CEO Eric Schlorff, are buying shares—showing strong confidence in the company’s medical‑device growth and potential upside.